27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Medtronic (NYSE:MDT) shares are trading higher on Wednesday after the company announced it would acquire an artificial intelligence surgery company Medicrea.
Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The company markets its products to health care institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Medtronic shares were trading up 2.70% at $97.21 during the time of publication on Wednesday. The stock has a 52-week high of $122.15 and a 52-week low of $72.13.
Related Links:
Medtronic Reports Q2 Earnings Beat, Raises Guidance
Musk Says Tesla Has 'Extra' Ventilators Ready For Shipping
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.